Relationship between overnight neuroendocrine activity and morning haemostasis in working men

Clinical Science - Tập 107 Số 1 - Trang 89-95 - 2004
Roland von Känel1,2, Brigitte M. Kudielka2, A. R. K. Abdel-Razik2, Marie‐Louise Gander1,2, Karl Frey2, Joachim E. Fischer2
1Department of General Internal Medicine, University Hospital, Berne, Switzerland
2Institute for Behavioral Sciences, Federal Institute of Technology, Zürich, Switzerland

Tóm tắt

Sustained effects of SNS (sympathetic nervous system) and HPAA (hypothalamic–pituitary–adrenal axis) hyperactivity on haemostasis have not been investigated. In the present study, we tested for an association of overnight urinary catecholamine and cortisol excretion with morning plasma levels of fibrinogen, PAI-1 (plasminogen activator inhibitor-1) and D-dimer. Participants (639 male industrial employees) with a complete dataset were studied (age, 41±11 years; mean±S.D.). Subjects collected overnight urinary samples and had a fasting morning blood sample drawn. Measurement of urinary adrenaline (epinephrine), noradrenaline (norepinephrine) and cortisol were dichotomized to perform multivariate analyses of (co)variance. Haemostatic parameters were measured by ELISA. Fibrinogen was higher in men with high adrenaline (F7,631=5.68, P=0.018; where the subscripted value represents the degrees of freedom) and high noradrenaline (F7,631=4.19, P=0.041) compared with men with low excretion of the respective hormones. PAI-1 was higher in men with high cortisol than in men with low cortisol (F7,631=4.77, P=0.029). Interaction revealed that subjects with high cortisol/low noradrenaline had higher PAI-1 than subjects with low cortisol/high noradrenaline (P=0.038). Subjects with high adrenaline/high noradrenaline had higher D-dimer than subjects with high adrenaline/low noradrenaline (P=0.029), low adrenaline/high noradrenaline (P=0.022) and low adrenaline/low noradrenaline (not significant). When covariance for several confounders of haemostatic function was determined, the main effect of adrenaline on fibrinogen and the interaction between adrenaline and noradrenaline for D-dimer maintained significance. Although overnight SNS hyperactivity was associated independently with morning hypercoagulability, the relationship between the activity of HPAA and haemostasis was mediated by traditional cardiovascular risk factors.

Từ khóa


Tài liệu tham khảo

Imhof, 2001, Exercise and thrombosis, Cardiol. Clin., 19, 389, 10.1016/S0733-8651(05)70224-1

von Känel, 2001, Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease?, Psychosom. Med., 63, 531, 10.1097/00006842-200107000-00003

von Känel, 2000, Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo, Eur. J. Haematol., 65, 357, 10.1034/j.1600-0609.2000.065006357.x

Wallen, 1999, Activation of haemostasis by exercise, mental stress and adrenaline: effects on platelet sensitivity to thrombin and thrombin generation, Clin. Sci., 97, 27, 10.1042/CS19990013

von Känel, 2002, Effect of β2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress, Am. Heart J., 144, 68, 10.1067/mhj.2002.123146

Cannon, 1914, Factors affecting the coagulation time of blood. IV. The hastening of coagulation in pain and emotional excitement, Am. J. Physiol., 34, 251, 10.1152/ajplegacy.1914.34.2.251

von Känel, 2003, Acute procoagulant stress response as a dynamic measure of allostatic load in Alzheimer caregivers, Ann. Behav. Med., 26, 42, 10.1207/S15324796ABM2601_06

Koenig, 2003, Fibrin(ogen) in cardiovascular disease: an update, Thromb. Haemostasis, 89, 601, 10.1055/s-0037-1613566

Kohler, 2000, Plasminogen-activator inhibitor type 1 and coronary artery disease, N. Engl. J. Med., 342, 1792, 10.1056/NEJM200006153422406

Danesh, 2001, Fibrin D-dimer and coronary heart disease: prospective study and meta analysis, Circulation., 103, 2323, 10.1161/01.CIR.103.19.2323

Kohler, 2002, Insulin resistance syndrome: interaction with coagulation and fibrinolysis, Swiss Med. Wkly., 132, 241

von Känel, 2003, Hemostatic alterations in obstructive sleep apnea patients and the implications for cardiovascular disease, Chest, 124, 1956, 10.1378/chest.124.5.1956

Lowe, 2001, C-reactive protein, fibrin D dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?, Arterioscler., Thromb., Vasc. Biol., 21, 603, 10.1161/01.ATV.21.4.603

Michael, 1999, Health behaviors, social networks, and healthy aging: cross-sectional evidence from the Nurses' Health Study, Qual. Life. Res., 8, 711, 10.1023/A:1008949428041

Jonsson, 1995, Job control, job demands and social support at work in relation to cardiovascular risk factors in MONICA 1995, Goteborg, J. Cardiovasc. Risk, 6, 379, 10.1177/204748739900600604

Jenkins, 1988, A scale for the estimation of sleep problems in clinical research, J. Clin. Epidemiol., 41, 313, 10.1016/0895-4356(88)90138-2

Clauss, 1957, Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens, Acta Haematol., 17, 237, 10.1159/000205234

von Känel, 2003, Effects of non-specific β-adrenergic stimulation and blockade on blood coagulation in hypertension, J. Appl. Physiol., 94, 1455, 10.1152/japplphysiol.00892.2002

Teger-Nilsson, 1991, Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of β blockade, Circulation, 84, VI72

Jorgensen, 1982, Effect of glucocorticosteroids on some coagulation tests, Acta Haematol., 68, 39, 10.1159/000206946

Isacson, 1970, Effects of prednisolone on the coagulation and fibrinolytic systems, Scand. J. Haemat., 7, 212, 10.1111/j.1600-0609.1970.tb01890.x

Krentz, 1996, Insulin resistance, Br. Med. J., 313, 1385, 10.1136/bmj.313.7069.1385

Juhan-Vague, 2000, Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity, Ann. Med., 32, 78

Brunner, 2002, Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study, Circulation, 106, 2659, 10.1161/01.CIR.0000038364.26310.BD

Hansen, 2001, Seasonal and biological variation of urinary epinephrine, norepinephrine, and cortisol in healthy women, Clin. Chim. Acta, 309, 25, 10.1016/S0009-8981(01)00493-4

Maes, 1997, Components of biological variation, including seasonality, in blood concentrations of TSH, TT3, FT4, PRL, cortisol and testosterone in healthy volunteers, Clin. Endocrinol., 46, 587, 10.1046/j.1365-2265.1997.1881002.x

Curtin, 1996, Day-to-day intraindividual reliability and interindividual differences in monoamines excretion, J. Affect. Disord., 38, 173, 10.1016/0165-0327(96)00011-0

Folsom, 2001, Hemostatic risk factors for atherothrombotic disease: an epidemiologic view, Thromb. Haemostasis, 86, 366, 10.1055/s-0037-1616234

Chandler, 1997, Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels, Circulation, 96, 761, 10.1161/01.CIR.96.3.761

Juhan-Vague, 1996, Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities, Circulation, 94, 2057, 10.1161/01.CIR.94.9.2057

Kluft, 1988, Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1), Thromb. Haemostasis, 59, 329, 10.1055/s-0038-1642781

Bremner, 2000, Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men, Am. Heart J., 139, 164, 10.1016/S0002-8703(00)90324-7

Jafri, 1992, Circadian variation in platelet function in healthy volunteers, Am. J. Cardiol., 69, 951, 10.1016/0002-9149(92)90799-5

Mittleman, 1995, Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators, Circulation, 92, 1720, 10.1161/01.CIR.92.7.1720

Mittleman, 1993, Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators, N. Engl. J. Med., 329, 1677, 10.1056/NEJM199312023292301

Virmani, 2000, Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions, Arterioscler., Thromb., Vasc. Biol., 20, 1262, 10.1161/01.ATV.20.5.1262

Falk, 1995, Role of thrombosis in atherosclerosis and its complications, Am. J. Cardiol., 75, 3B, 10.1016/0002-9149(95)80003-B

Andreotti, 1999, Circadianicity of hemostatic function and coronary vasomotion, Cardiologia., 44, 245

Andrews, 1996, Mechanisms underlying the morning increase in platelet aggregation: a flow cytometry study, J. Am. Coll. Cardiol., 28, 1789, 10.1016/S0735-1097(96)00398-1

Muller, 1999, Circadian variation in cardiovascular events, Am. J. Hypertens., 12, 35S, 10.1016/S0895-7061(98)00278-7

McEwen, 1998, Stress, adaptation, and disease. Allostasis and allostatic load, Ann. N.Y. Acad. Sci., 840, 33, 10.1111/j.1749-6632.1998.tb09546.x